End-of-day quote
Korea S.E.
06:00:00 2024-04-29 pm EDT
5-day change
1st Jan Change
34,500
KRW
+0.58%
+0.29%
-10.16%
Master Meditech Inc. announced that it has received KRW 8 billion in funding from Samho Green Investment, Inc., Paratus Investment Inc., Spring Camp, Huons Co., Ltd., Pharmbio Co., Ltd., INNOCENCE Co.Ltd
Master Meditech Inc. announced that it has raised KRW 8,000,000,000 in its series A round of funding on March 29, 2021. The transaction involved participation from Samho Green Investment, Inc., CP Partners LLC, a fund managed by Paratus Investment Inc., Spring Camp, Huons Co., Ltd. (KOSDAQ:A243070), Pharmbio Co., Ltd., INNOCENCE Co.Ltd, King Mind Partners, and Foresite-Cape Bio New Technology Investment Association.
PanGen Biotech Inc. announced that it has received KRW 3.999986631 billion in funding from CrystalGenomics Invites Co., LTD., Huons Co., Ltd., Hwail Pharmaceutical Co.,Ltd.
Mar. 26
CI
Huons Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Mar. 20
CI
PanGen Biotech Inc. announced that it expects to receive KRW 3.999986631 billion in funding from CrystalGenomics Invites Co., LTD., Huons Co., Ltd., Hwail Pharmaceutical Co.,Ltd.
Mar. 17
CI
GenEdit Inc. announced that it has received $24 million in funding from Korea Innovative Medicines Consortium, Dong-A ST Co., Ltd., Huons Co., Ltd.
Jan. 23
CI
Huons Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
23-03-23
CI
South Korea's Huons to Export Anesthetics to Canada
23-03-01
MT
GenEdit Inc. amended terms of the transaction
23-02-27
CI
South Korean Stocks Turn Upbeat as China COVID-19 Lockdown Restrictions Ease; Huons Adds 1%
22-11-29
MT
Huons to Invest $18.3 Million to Raise Production Capacity for Injectable Products at Jecheon Plant
22-11-29
MT
GenEdit Inc. announced that it expects to receive $30 million in funding
22-11-08
CI
Haemato : to Seek EU Approval for Botox Product
21-10-25
MT
PanGen Biotech Inc. announced that it has received KRW 9.99998571 billion in funding from Huons Co., Ltd. and another investor
21-06-10
CI
PanGen Biotech Inc. announced that it expects to receive KRW 9.99998571 billion in funding from Huons Co., Ltd., and another investor
21-06-02
CI
Pharmcadd Co, Ltd announced that it has received $16 million in funding from a group of investors
21-04-18
CI
Master Meditech Inc. announced that it has received KRW 8 billion in funding from Samho Green Investment, Inc., Paratus Investment Inc., Spring Camp, Huons Co., Ltd., Pharmbio Co., Ltd., INNOCENCE Co.Ltd
21-03-28
CI
Tranche Update on Huons Co., Ltd.'s Equity Buyback Plan announced on August 14, 2020.
21-02-23
CI
Tranche Update on Huons Co., Ltd.'s Equity Buyback Plan announced on August 14, 2020.
21-02-23
CI
Huons Co., Ltd.'s Equity Buyback announced on August 14, 2020, has expired with 80,102 shares, representing 0.74% for KRW 4,989.56 million.
21-02-17
CI
LIPAC Oncology Announces Major Partnering Milestone Achieved in Its License Agreement with Huons Co., Ltd
20-12-10
CI
Tranche Update on Huons Co., Ltd.'s Equity Buyback Plan announced on August 14, 2020.
20-11-23
CI
Huons Co., Ltd. announced that it has received KRW 50 billion in funding from a group of investors
20-11-12
CI
Huons Co., Ltd. announced that it expects to receive KRW 50 billion in funding from a group of investors
20-11-10
CI
Huons Co., Ltd. announces an Equity Buyback for KRW 5,000 million worth of its shares.
20-08-14
CI
Huons Co., Ltd. authorizes a Buyback Plan.
20-08-13
CI
LIPAC Oncology and Huons Co. Announces Exclusive Licensing Agreement for TSD-001 in Korea
19-09-16
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Huons Co., Ltd. is a Korea-based company principally engaged in manufacture of general medicine and special medicine.
More about the company
Last Close Price
34,500
KRW
Average target price
54,000
KRW
Spread / Average Target
+56.52%
Consensus
1st Jan change
Capi.
-10.16% 296M +34.00% 704B +27.45% 577B -7.75% 348B +18.53% 327B +4.95% 288B +14.81% 234B +4.93% 198B -9.78% 194B -4.89% 147B
Other Pharmaceuticals
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1